Lecomte M C, Garbarz M, Gautero H, Bournier O, Galand C, Boivin P, Dhermy D
Laboratoire de Pathologie Cellulaire et Moléculaire en Hématologie INSERM, Association Claude Bernard, Hôpital Beaujon, Clichy, France.
Br J Haematol. 1993 Nov;85(3):584-95. doi: 10.1111/j.1365-2141.1993.tb03352.x.
The impaired ability of spectrin dimers to self-associate into tetramers is one of the most frequent defects associated with hereditary elliptocytosis (HE) and its more serious form, hereditary pyropoikylocytosis (HPP). We previously described four proteic variants of the spectrin (Sp) alpha I tryptic domain associated with the Sp dimer self-association defect (Sp alpha I/78, Sp alpha I/74, Sp alpha I/65, Sp alpha I/46 variants). Following the characterization of proteic variants, genomic molecular defects were identified and most of the mutations appeared to lie either in or near the self-association site, i.e. in the alpha I tryptic domain or in the beta I tryptic domain. The clinical severity of these different mutations varies considerably and ranges from asymptomatic to severe haemolytic disease such as in heterozygous HPP patients and in some homozygous HE patients. Studies of 113 patients from 61 HE families showed a correlation among parameters and showed which factors modulate the clinical expression of the molecular defect. Our analysis indicated that the clinical expression was directly correlated with the severity of the spectrin dimer self-association defect as evaluated by the increase in the Sp dimer percentage found in the 4 degrees C extract. A critical threshold of 40-50% of unassembled Sp dimer was determined; above that, patients exhibited severe haemolysis requiring splenectomy. The percentage of Sp dimer depends, in turn, on two factors: (i) the nature of the variant in relation to the position of the mutation versus the tetramerization site; (ii) the relative amount of mutant spectrin present in the membrane (ranging from 15% to 80% in heterozygous patients). As for the severity of haemolysis, the ghost mechanical stability to shear stress, as measured by ektacyometer, was also found to depend on the Sp dimer self-association defect. In contrast, the decrease in erythrocyte deformability was not related to the amount of unassembled Sp dimer but appeared to be correlated with the amount of mutant spectrin whatever the variant. Concerning erythrocyte morphology and the number of elliptocytes, the Sp alpha I/65 variant appears to be the most 'elliptocytogenic' variant, indicating that erythrocyte shape abnormality is not linked to the Sp dimer self-association defect.
血影蛋白二聚体自我缔合形成四聚体的能力受损是与遗传性椭圆形红细胞增多症(HE)及其更严重形式遗传性热异形红细胞增多症(HPP)相关的最常见缺陷之一。我们之前描述了与血影蛋白(Sp)αI胰蛋白酶结构域相关的四种蛋白质变体,它们与Sp二聚体自我缔合缺陷有关(SpαI/78、SpαI/74、SpαI/65、SpαI/46变体)。在对蛋白质变体进行表征之后,确定了基因组分子缺陷,并且大多数突变似乎位于自我缔合位点内或附近,即在αI胰蛋白酶结构域或βI胰蛋白酶结构域中。这些不同突变的临床严重程度差异很大,范围从无症状到严重溶血性疾病,如杂合子HPP患者和一些纯合子HE患者。对来自61个HE家族的113名患者的研究显示了参数之间的相关性,并表明了哪些因素调节分子缺陷的临床表达。我们的分析表明,临床表达与血影蛋白二聚体自我缔合缺陷的严重程度直接相关,这通过在4℃提取物中发现的Sp二聚体百分比的增加来评估。确定了未组装的Sp二聚体的临界阈值为40 - 50%;高于该阈值,患者表现出严重溶血,需要进行脾切除术。Sp二聚体的百分比又取决于两个因素:(i)与突变相对于四聚化位点的位置相关的变体性质;(ii)膜中存在的突变血影蛋白的相对量(杂合子患者中为15%至80%)。至于溶血的严重程度,通过血沉棕黄层测定仪测量的血影对剪切应力的机械稳定性也被发现取决于Sp二聚体自我缔合缺陷。相比之下,红细胞变形性的降低与未组装的Sp二聚体的量无关,但无论变体如何,似乎都与突变血影蛋白的量相关。关于红细胞形态和椭圆形红细胞的数量,SpαI/65变体似乎是最“致椭圆形红细胞生成”的变体,这表明红细胞形状异常与Sp二聚体自我缔合缺陷无关。